Email this article Cytosinging syndrome at sick HCV-infection with the expressed fibrosis of the liver
- Authors: Vasilev SU1
-
Affiliations:
- Самарский государственный медицинский университет
- Issue: Vol 14, No 1-2 (2014)
- Pages: 23-26
- Section: Articles
- URL: https://ogarev-online.ru/2410-3764/article/view/24431
- DOI: https://doi.org/10.17816/2072-2354.2014.0.1-2.23-26
- ID: 24431
Cite item
Full Text
Abstract
The work purpose is to investigate features of the hematologic status in patients with the HCV-infection in combination with the expressed fibrosis of a liver. The group of patients by the HCV-infection (n=376) ranging in age from 38 to 80 lasting disease with more than 10 years is surveyed. On the basis of dynamic supervision of patients, laboratory monitoring and the statistical analysis the interrelation of a stage of fibrosis of a liver in patients with a HCV-infection with a cytosinging syndrome were confirmed. It is shown that the stage of fibrosis of a liver is associated with degree thrombocytopenia and pan-cytosinging liver disease among patients with НСV lasting disease with more than 10 years, the cytosinging syndrome occurs in 39% of cases, among them one-proliferous cytosinging is 65,6%, two-proliferous is 26,4%, pan-cytosinging - 8,1%.
References
- Giannini E.Reviewarticle: Thrombocytopeniainchronicliverdiseaseandpharmacologictreatmentoptions. Aliment.Pharmacol. Ther. 2006; 23: 1055-65.
- McHutchison J.G., Afdhal N., Shiffman M.L. et al. Efficacy and safety of eltrombopag, an oral platelet growth factor, in subjects with HCV associated thrombocytopenia: preliminary results from a phase II dose-ranging study. J. Hepatol. 2006; 44 (Suppl. 2): A 745.
- МсHutchisonJ., MannsM., PatelK. etal. Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. Gastroenterology 2002; 123: 1061-1069.
- Жданов, К.В. Клинико-иммунологические, вирусологические и морфологические взаимосвязи при хроническом гепатите C [Текст] / К.В. Жданов, Д.А. Гусев, В.С. Чирский и др. // Вестн. Рос.воен. мед. акад. - 2007. - № 2(18). - С. 78-82.
- Schofski P., Tacke F., Trautwein C. et al. Thrombopoietin serum levels are elevated in patients with hepatitis B/C infection compared to other causes of chronic liver disease. Liver 2002; 22 (2): 114-20.
- Peck-Radosavljevic M. Thrombocytopenia in liver disease.Can. J. Gastroenterol. 2000; 14 (Suppl. D): 60-66.
- Tovey M., Lallemand C. Pharmaceuticals, 2010. Masumi A. et al. Advances in Hematopoietic Stem Cell Research, 2012.
- Патент RU 2425633 C2. Способ неинвазивного определения стадии фиброза печени у пациентов с хроническим вирусным гепатитом.
- Лукина Е.А., Сысоева Е.П., Луговская С.А. и др. Гематологические синдромы у больных хроническим гепатитом С // Терапевтический архив. - 2000. - № 7. - С. 60-62.
- Adinolfi LE, Giordano MG, Andreana A, et al. Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis. Brit J Haematol 2001;113:590-595.
- Afdhal N, McHutchison J, Brown R, et al. Thrombocytopenia associated with chronic liver disease. J Hepatol 2008; 48:1000-1007.
- Weksler BB. Review article: the pathophysiology of thrombocytopenia in hepatitis C virus infection and chronic liver disease. Aliment Pharmacol Ther 2007;26 (Suppl 1):13-19.
Supplementary files
